GITMO Registry Study on Allogeneic Transplantation in Patients Aged ≥60 Years from 2000 to 2017: Improvements and Criticisms
Open Access
- 1 February 2022
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 28 (2) , 96.e1-96.e11
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Comparative study on ATG-thymoglobulin versus ATG-fresenius for the graft-versus-host disease (GVHD) prophylaxis in allogeneic stem cell transplantation from matched unrelated donor: a single-centre experience over the contemporary yearsLeukemia & Lymphoma, 2018
- Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panelBlood, 2017
- Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host DiseaseNew England Journal of Medicine, 2016
- Prediction of Allogeneic Hematopoietic Stem-Cell Transplantation Mortality 100 Days After Transplantation Using a Machine Learning Algorithm: A European Group for Blood and Marrow Transplantation Acute Leukemia Working Party Retrospective Data Mining StudyJournal of Clinical Oncology, 2015
- Conditioning regimens for hematopoietic cell transplantation: one size does not fit allBlood, 2014
- Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipientsHaematologica, 2014
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Reduced Mortality after Allogeneic Hematopoietic-Cell TransplantationNew England Journal of Medicine, 2010
- Risk score for outcome after allogeneic hematopoietic stem cell transplantationCancer, 2009
- Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCTBlood, 2005